Skip to main content
. 2021 Mar 9;35(4):447–452. doi: 10.1177/0269881121996863

Table A3.

Lifetime classic psychedelic use predicting heart condition only, cancer only, and both heart condition and cancer in the past year.

aRRR (95% CI) p value N
No heart condition or cancer (Reference) 161,036
Heart condition only in the past year 0.89 (0.76–1.05) . 1752 5563
Cancer only in the past year 0.86 (0.67–1.11) .2452 1328
Both heart condition and cancer in the past year 0.98 (0.43–2.25) .9681 220

aRRR: adjusted relative risk ratio; CI: confidence interval; N refers to unweighted counts in each row; relative risk ratios are adjusted for age, sex, sexual orientation, ethnoracial identity, educational attainment, annual household income, marital status, self-reported engagement in risky behaviour, lifetime use of cocaine, other stimulants, sedatives, tranquilizers, heroin, pain relievers, marijuana, phencyclidine (PCP), 3,4-methylenedioxymethamphetamine (MDMA/ecstasy), inhalants, smokeless tobacco, pipe tobacco, cigar and cigarettes daily, and age of first alcohol use.